Highly Active Antiretroviral Therapy (HAART)

A312701_1_En_26_Fig1b_HTML.jpgA312701_1_En_26_Fig1c_HTML.jpgA312701_1_En_26_Fig1d_HTML.jpg



Fig. 26.1
CNS PML-IRIS. The patient was HIV positive and presented with subacute onset of right-sided weakness, slurred speech, and left beating nystagmus. The CD4 count at admission was 5 and the viral load was 82,000. The patient was then started on HAART with three drugs (efavirenz , tenofovir, and emtricitabine). Axial FLAIR (a, b) and post-contrast T1-weighted (c, d) MR images at initial presentation show patchy areas of signal abnormality without associated enhancement in the brainstem, cerebellum, and right basal ganglia. Subsequently, the patient presented with worsening neurologic symptoms, although the viral load decreased to 96 and the CD4 count increased to 11. Axial FLAIR (eh) and post-contrast T1 (il) MR images obtained 1 month after initial presentation show marked interval progression of the signal abnormality in the brainstem, cerebellum, and supratentorial white matter with patchy enhancement (arrows). Corresponding DWI (m) and ADC map (n) show elevated diffusion in the affected white matter




Table 26.1
Imaging findings for the different types of IRIS































Pathogen

Neuroimaging findings

JC virus PML

Interstitial edema, mass effect, and on contrast T1WI parenchymal and perivascular enhancement

Mycobacterium tuberculosis

Tuberculoma, basal leptomeningeal enhancement, and hydrocephalus

Atypical mycobacterium

Lymphadenitis; rarely enhancing lesions in the brain

Cytomegalovirus

Cerebral vasculitis and infarcts; ventriculitis; retinitis

Varicella

Cerebral vasculitis and infarcts, which may be associated with parenchymal and leptomeningeal enhancement

Cryptococcus

Lymphadenitis; gelatinous pseudocysts with restricted diffusion and parenchymal enhancement; cryptococcoma meningitis with meningeal or choroid plexus enhancement

Toxoplasma

Focal-enhancing parenchymal mass lesions, often with edema


The keys to the diagnosis of IRIS are the symptomatic and radiologic progression of disease after the initiation of HAART, despite an increasing CD4 T-cell count and the suppression of HIV viremia and the absence of a new opportunistic infection. Treatment for CNS IRIS related to HAART mainly consists of steroids. Patients may succumb to the disease, with mortality rates as high as 30 %.



26.4 Differential Diagnosis


The main alternative diagnostic considerations to IRIS include treatment failure and opportunistic infections without the superimposed effects of HAART. The imaging manifestations of opportunistic infections depend upon the specific pathogen, such as the JC virus, toxoplasmosis, Mycobacterium tuberculosis, or Cryptococcus.

Nov 3, 2016 | Posted by in NEUROLOGY | Comments Off on Highly Active Antiretroviral Therapy (HAART)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access